Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

Clinical trial NCT06953726 · RECRUITING

Trial details

NCT number: NCT06953726
Sponsor: VA Office of Research and Development
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation

Start date: 2026-06-01
Primary completion: 2032-10-04
Enrollment: 10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.